These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36803703)

  • 1. Deprescribing Antihypertensive Medications in Older People: A Narrative Review, Part 1.
    Russell P; Thompson C; Mangoni AA
    Sr Care Pharm; 2023 Mar; 38(3):76-85. PubMed ID: 36803703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Prescribing and Deprescribing of Antihypertensive Medications in Older People, a Three-Part Narrative Review, Part 3.
    Russell P; Thompson C; Mangoni AA
    Sr Care Pharm; 2023 May; 38(5):168-178. PubMed ID: 37185147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Prescribing and Deprescribing of Antihypertensive Medications in Older People, Part 2.
    Russell P; Thompson C; Mangoni AA
    Sr Care Pharm; 2023 Apr; 38(4):128-140. PubMed ID: 36949557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
    Triantafylidis LK; Hawley CE; Perry LP; Paik JM
    Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial.
    Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ;
    JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive Deprescribing in Older Adults: a Practical Guide.
    Sheppard JP; Benetos A; McManus RJ
    Curr Hypertens Rep; 2022 Nov; 24(11):571-580. PubMed ID: 35881225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.
    Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ
    Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescribing and deprescribing in very old age: perceptions of very old adults, caregivers and health professionals.
    Ouellet N; Bergeron AS; Gagnon E; Cossette B; Labrecque CA; Sirois C
    Age Ageing; 2022 Nov; 51(11):. PubMed ID: 36413585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
    Shantsila E; Lip GYH; Shantsila A; Kurpas D; Beevers G; Gill PS; Williams NH
    J Hypertens; 2023 Oct; 41(10):1502-1510. PubMed ID: 37432893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication use quality and safety in older adults: 2020 update.
    Eshetie TC; Marcum ZA; Schmader KE; Gray SL
    J Am Geriatr Soc; 2022 Feb; 70(2):389-397. PubMed ID: 34897654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication Use Quality and Safety in Older Adults: 2018 Update.
    Ailabouni NJ; Marcum ZA; Schmader KE; Gray SL
    J Am Geriatr Soc; 2019 Dec; 67(12):2458-2462. PubMed ID: 31765004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy, the Elderly, and Deprescribing.
    Jetha S
    Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate deprescribing in older people: a challenging necessityCommentary to accompany themed collection on deprescribing.
    van der Velde N; Minhas JS
    Age Ageing; 2021 Sep; 50(5):1516-1519. PubMed ID: 34260681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.
    Brokaar EJ; van den Bos F; Visser LE; Portielje JEA
    Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.